Su-Jung Kim

Dr. Su-Jung Kim

College of Pharmacy, Seoul National University, Seoul 08826, South Korea
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Cancer Letters
Verified
Journal Article
Closed access
SKSu-Jung Kim
Su-Jung Kim
SSSoma Saeidi
Soma Saeidi
NCNam-Chul Cho
Nam-Chul Cho
SKSeung Hyeon Kim
Seung Hyeon Kim
HLHan-Byoel Lee
Han-Byoel Lee
Young-Joon SurhYoung-Joon Surh
Young-Joon Surh

30 December 2020 in Cancers
Verified
Journal Article
Open access
PDF file
YHyoung Il Hahn
young Il Hahn
SSSoma Saeidi
Soma Saeidi
SKSu-Jung Kim
Su-Jung Kim
SPSe-Young Park
Se-Young Park
NSNa-Young Song
Na-Young Song
Young-Joon SurhYoung-Joon Surh
Young-Joon Surh
Signal transducer and activator of transcription 3 (STAT3) and nuclear factor-κB (NF-κB) are two representative transcription factors that play a critical role in inflammation-associated tumorigenesis through multi-level cooperation. Unlike other types of tumors, breast carcinomas have shown a significant dependency on the non-classical NF-κB pathway as well as the classical one. The α subunit of the inhibitor of the κB kinase (IKK) complex, IKKα, is involved in both classical and non-classical activation of NF-κB. Although the cross-talk between STAT3 and NF-κB has been suggested in several studies, the interplay between STAT3 and the regulators of NF-κB including IKKα has not been fully clarified yet. In this study, we observed overexpression and co-localization of IKKα and STAT3 in human breast cancer tissues as well as in H-Ras transformed human breast epithelial (H-Ras MCF-10A) and breast cancer (MDA-MB-231) cells. By utilizing small interfering RNA (siRNA) technology, we were able to demonstrate that STAT3 up-regulated IKKα, but not IKKβ or IKKγ, in these cells. This was attributable to direct binding to and subsequent stabilization of IKKα protein by blocking the ubiquitin-proteasome system. Notably, we identified the lysine 44 residue of IKKα as a putative binding site for STAT3. Moreover, siRNA knockdown of IKKα attenuated viability, anchorage-independent growth and migratory capabilities of H-Ras MCF-10A cells. Taken together, these findings propose a novel mechanism responsible for NF-κB activation by STAT3 through stabilization of IKKα, which contributes to breast cancer promotion and progression. Thus, breaking the STAT3-IKKα alliance can be an alternative therapeutic strategy for the treatment of breast cancer.

30 June 2021 in Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
KCKyunghwa Cho
Kyunghwa Cho
HLHee Geum Lee
Hee Geum Lee
JPJuan-Yu Piao
Juan-Yu Piao
SKSu-Jung Kim
Su-Jung Kim
HNHye-Kyung Na
Hye-Kyung Na
Young-Joon SurhYoung-Joon Surh
Young-Joon Surh
Kyunghwa Cho, Hee Geum Lee, Juan-Yu Piao, Su-Jung Kim, Hye-Kyung Na, Young-Joon Surh. J Cancer Prev 2021;26:118-27. https://doi.org/10.15430/JCP.2021.26.2.118

25 November 2022 in Life Sciences
Verified
Journal Article
Closed access
XFXizhu Fang
Xizhu Fang
YLYeon-Hwa Lee
Yeon-Hwa Lee
JJJeong-Hoon Jang
Jeong-Hoon Jang
SKSu-Jung Kim
Su-Jung Kim
SKSeong Hoon Kim
Seong Hoon Kim
Young-Joon SurhYoung-Joon Surh
Young-Joon Surh

14 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HYHye-Won Yum
Hye-Won Yum
JPJin Park
Jin Park
HPHyun Jung Park
Hyun Jung Park
JSJun Wan Shin
Jun Wan Shin
Yong-Yeon ChoYong-Yeon Cho
Yong-Yeon Cho
Young-Joon SurhYoung-Joon Surh
Young-Joon Surh
The present study was intended to explore the effects of endogenously produced ω-3 polyunsaturated fatty acids (PUFAs) on ultraviolet B (UVB)-induced skin inflammation and photocarcinogenesis using hairless fat-1 transgenic mice harboring ω-3 desaturase gene capable of converting ω-6 to ω-3 PUFAs. Upon exposure to UVB irradiation, fat-1 transgenic mice exhibited a significantly reduced epidermal hyperplasia, oxidative skin damage, and photocarcinogenesis as compared to wild type mice. The transcription factor, Nrf2 is a master regulator of anti-inflammatory and antioxidant gene expression. While the protein expression of Nrf2 was markedly enhanced, the level of its mRNA transcript was barely changed in the fat-1 transgenic mouse skin. Topical application of docosahexaenoic acid (DHA), a representative ω-3 PUFA, in wild type hairless mice induced expression of the Nrf2 target protein, heme oxygenase-1 in the skin and protected against UVB-induced oxidative stress, inflammation and papillomagenesis. Furthermore, transient overexpression of fat-1 gene in mouse epidermal JB6 cells resulted in the enhanced accumulation of Nrf2 protein. Likewise, DHA treated to JB6 cells inhibited Nrf2 ubiquitination and stabilized it. Taken together, our results indicate that functional fat-1 and topically applied DHA potentiate cellular defense against UVB-induced skin inflammation and photocarcinogenesis through elevated activation of Nrf2 and upregulation of cytoprotective gene expression.

16 March 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
SKSeung Hyeon Kim
Seung Hyeon Kim
SKSu-Jung Kim
Su-Jung Kim
JPJeongmin Park
Jeongmin Park
YJYeonsoo Joe
Yeonsoo Joe
SLSo Eui Lee
So Eui Lee
Young-Joon SurhYoung-Joon Surh
Young-Joon Surh
Tumor-associated macrophages (TAMs) represent one of the most abundant components of the tumor microenvironment and play important roles in tumor development and progression. TAMs display plasticity and functional heterogeneity as reflected by distinct phenotypic subsets. TAMs with an M1 phenotype have proinflammatory and anti-tumoral properties whereas M2-like TAMs exert anti-inflammatory and pro-tumoral functions. Tumor cell debris generated during chemotherapy can stimulate primary tumor growth and recurrence. According to our previous study, phagocytic engulfment of breast tumor cell debris by TAMs attenuated chemotherapeutic efficacy through the upregulation of heme oxygenase-1 (HO-1). To verify the impact of HO-1 upregulation on the profile of macrophage polarization during cytotoxic therapy, we utilized a syngeneic murine breast cancer (4T1) model in which tumor bearing mice were treated with paclitaxel (PTX). PTX treatment markedly downregulated the surface expression of the M1 marker CD86 in infiltrated TAMs. Notably, there were significantly more cytotoxic CD8+ T cells in tumors of mice treated with PTX plus the HO-1 inhibitor, zinc protophorphyrin IX (ZnPP) than in mice treated with PTX alone. Interestingly, the tumor-inhibiting efficacy of PTX and ZnPP co-treatment was abrogated when macrophages were depleted by clodronate liposomes. Macrophage depletion also decreased the intratumoral CD8+ T cell population and downregulated the expression of Cxcl9 and Cxcl10. The expression of the M1 phenotype marker, CD86 was higher in mice injected with PTX plus ZnPP than that in mice treated with PTX alone. Conversely, the PTX-induced upregulation of the M2 marker gene, Il10 in CD11b+ myeloid cells from 4T1 tumor-bearing mice treated was dramatically reduced by the administration of the HO-1 inhibitor. Genetic ablation of HO-1 abolished the inhibitory effect of 4T1 tumor cell debris on expression of M1 marker genes, Tnf and Il12b, in LPS-stimulated BMDMs. HO-1-deficient BMDMs exposed to tumor cell debris also exhibited a diminished expression of the M2 macrophage marker, CD206. These findings, taken all together, provide strong evidence that HO-1 plays a pivotal role in the transition of tumor-inhibiting M1-like TAMs to tumor-promoting M2-like ones during chemotherapy.